I am confused about whether virtual doctors can prescribe GLP 1 weight loss drugs legally across state lines in the US right now
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
I am confused about whether virtual doctors can prescribe GLP 1 weight loss drugs legally across state lines in the US right now
3 real searches · 1 real-search pass
2026 US telehealth physician licensing across state lines patient located state medical board telemedicine prescribing GLP-1 lawsGoogle ↗
OBSERVED
FDA 2026 semaglutide tirzepatide compounding shortage resolved enforcement policy GLP-1Google ↗
OBSERVED
DEA telemedicine prescribing controlled substances 2026 GLP-1 not controlled substance Ryan HaightGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 US telehealth physician licensing across state lines patient located state medical board telemedicine prescribing GLP-1 laws Google ↗
FDA 2026 semaglutide tirzepatide compounding shortage resolved enforcement policy GLP-1 Google ↗
DEA telemedicine prescribing controlled substances 2026 GLP-1 not controlled substance Ryan Haight Google ↗
- HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026 · hhs.gov
- Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, 61301-61306 [2025-24123] :: Drug Enforcement Administration :: Department Of Justice :: Regulation Tracker :: Justia · regulations.justia.com
- Licensing across state lines · telehealth.hhs.gov
- Federation of State Medical Boards · fsmb.org
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize · fda.gov
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · fda.gov
- FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs · fda.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 US telehealth physician licensing across state lines patient located state medical board telemedicine prescribing GLP-1 laws OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA 2026 semaglutide tirzepatide compounding shortage resolved enforcement policy GLP-1 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
DEA telemedicine prescribing controlled substances 2026 GLP-1 not controlled substance Ryan Haight OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |